Australia is coming under increasing pressure from international drug companies demanding higher prices for their drugs.
In some cases, negotiations have broken down and companies have said they’ll withdraw their drugs from the market. In other cases, companies have said they’ll not apply for their drug to be listed on the Pharmaceutical Benefits Scheme (PBS) at all.